Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool – tapping into Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.
Watson Health helps to support the mission of California's Valued Trust by providing the underlying analytic architecture needed to understand what’s driving cost and trend in various regions. ...read more
Health Quest Medical Practice uses Watson Health solutions to supplement the information in their EHR. Learn how access to enhanced data has helped close patient care gaps and track quality measures. ...read more